You are viewing a single comment's thread from:
RE: Engineering Human B Cells With CRISPR
I know B cells are implicated in systemic lupus. So far, drug therapies targeting these cells have had limited success. You mention cancer therapies--I wonder, wouldn't this gene modification also potentially be useful in developing drug therapies for lupus?
It could be useful for a variety of issues pertaining to immune functionality yes.